TRACON Pharmaceuticals Reports Regulatory Approval of Envafolimab in China

NEXT STORY
Simply Better Brands Corp. Announces Third Quarter 2021 Results
PREV STORY
Celularity Announces FDA Clearance of Investigational New Drug Application (IND) for Natural Killer Cell Therapy CYNK-101 in First-line Advanced Her2/neu Positive Gastric and Gastroesophageal Junction Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Antimicrobial Susceptibility Testing Market Worth $5.09 billion by 2027 – Exclusive Report by Meticulous Research®

author_avatar
NASDAQ Market News

New data for Roche’s OCREVUS (ocrelizumab) reinforce significant benefit on slowing disease progression in relapsing and primary progressive multiple sclerosis

author_avatar
NASDAQ Market News

Versartis Announces Expansion of Executive Leadership Team with Addition of Dr. Robert Gut as the Head of Global Clinical, Medical and Regulatory Affairs

MENLO PARK, Calif., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused ...

author_avatar
NASDAQ Market News